Clinical Trial

Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

Study acronym: HOPE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a descriptive, retrospective study involving patients from private cardiology, nephrology, and dialysis clinics in Brazil who participated in the National Hyperkalaemia Diagnosis Campaign. The study used anonymised data from the Hi Technologies Ltda. database. The objective was to estimate and characterise the prevalence of hyperkalaemia (HK), as well as to analyse the demographic profile, clinical characteristics, risk factors and treatment patterns associated with total blood potassium levels.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-23
Trial Details
NCT Number NCT07370194
Lead Sponsor AstraZeneca
Conditions Hyperkalemia
Enrollment 6,215 participants
Start Date 2026-03-31
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24